Synthesis of a gadolinium based-macrocyclic MRI contrast agent for effective cancer diagnosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2055-7124
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Synthesis of a gadolinium based-macrocyclic MRI contrast agent for effective cancer diagnosis ; volume:22 ; number:1 ; day:13 ; month:6 ; year:2018 ; pages:1-8 ; date:12.2018
Biomaterials Research ; 22, Heft 1 (13.6.2018), 1-8, 12.2018
- Urheber
-
Jeong, Yohan
- Beteiligte Personen und Organisationen
-
Na, Kun
SpringerLink (Online service)
- DOI
-
10.1186/s40824-018-0127-9
- URN
-
urn:nbn:de:101:1-2018082119143362416328
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jeong, Yohan
- Na, Kun
- SpringerLink (Online service)
Ähnliche Objekte (12)
Macrocyclic MR contrast agents: evaluation of multiple-organ gadolinium retention in healthy rats
Gadolinium retention and clearance after administration of macrocyclic magnetic resonance contrast agents to rats
Gadolinium retention in gliomas and adjacent normal brain tissue: association with tumor contrast enhancement and linear/macrocyclic agents
Visible T1-hyperintensity of the dentate nucleus after multiple administrations of macrocyclic gadolinium-based contrast agents: yes or no?
Gadolinium-doped fluorescent carbon quantum dots as MRI contrast agents and fluorescent probes
Cerium oxide nanoparticles with antioxidant capabilities and gadolinium integration for MRI contrast enhancement
Investigation of the anthropogenic Gadolinium (Gd) anomaly: Specification Analysis of Gd-based MRI contrast agents
Application of Extracellular Gadolinium-based MRI Contrast Agents and the Risk of Nephrogenic Systemic Fibrosis
Application of Extracellular Gadolinium-based MRI Contrast Agents and the Risk of Nephrogenic Systemic Fibrosis
Drug monitoring of Gadolinium-based MRI contrast agents in rats: neurobehavioral, histological, and biochemical findings
Evaluating the potential of chelation therapy to prevent and treat gadolinium deposition from MRI contrast agents
Central nervous system gadolinium accumulation in patients undergoing periodical contrast MRI screening for hereditary tumor syndromes
Macrocyclic MR contrast agents: evaluation of multiple-organ gadolinium retention in healthy rats
Gadolinium retention and clearance after administration of macrocyclic magnetic resonance contrast agents to rats
Gadolinium retention in gliomas and adjacent normal brain tissue: association with tumor contrast enhancement and linear/macrocyclic agents
Visible T1-hyperintensity of the dentate nucleus after multiple administrations of macrocyclic gadolinium-based contrast agents: yes or no?
Gadolinium-doped fluorescent carbon quantum dots as MRI contrast agents and fluorescent probes
Cerium oxide nanoparticles with antioxidant capabilities and gadolinium integration for MRI contrast enhancement
Investigation of the anthropogenic Gadolinium (Gd) anomaly: Specification Analysis of Gd-based MRI contrast agents
Application of Extracellular Gadolinium-based MRI Contrast Agents and the Risk of Nephrogenic Systemic Fibrosis
Application of Extracellular Gadolinium-based MRI Contrast Agents and the Risk of Nephrogenic Systemic Fibrosis
Drug monitoring of Gadolinium-based MRI contrast agents in rats: neurobehavioral, histological, and biochemical findings
Evaluating the potential of chelation therapy to prevent and treat gadolinium deposition from MRI contrast agents
Central nervous system gadolinium accumulation in patients undergoing periodical contrast MRI screening for hereditary tumor syndromes
Macrocyclic MR contrast agents: evaluation of multiple-organ gadolinium retention in healthy rats
Gadolinium retention and clearance after administration of macrocyclic magnetic resonance contrast agents to rats
Gadolinium retention in gliomas and adjacent normal brain tissue: association with tumor contrast enhancement and linear/macrocyclic agents
Visible T1-hyperintensity of the dentate nucleus after multiple administrations of macrocyclic gadolinium-based contrast agents: yes or no?
Gadolinium-doped fluorescent carbon quantum dots as MRI contrast agents and fluorescent probes
Cerium oxide nanoparticles with antioxidant capabilities and gadolinium integration for MRI contrast enhancement
Investigation of the anthropogenic Gadolinium (Gd) anomaly: Specification Analysis of Gd-based MRI contrast agents
Application of Extracellular Gadolinium-based MRI Contrast Agents and the Risk of Nephrogenic Systemic Fibrosis
Application of Extracellular Gadolinium-based MRI Contrast Agents and the Risk of Nephrogenic Systemic Fibrosis
Drug monitoring of Gadolinium-based MRI contrast agents in rats: neurobehavioral, histological, and biochemical findings
Evaluating the potential of chelation therapy to prevent and treat gadolinium deposition from MRI contrast agents